Breakthrough in Gene Therapy: Researchers Develop Novel Method for Overcoming Endosomal Escape Limitations

Strategic Insights -

Researchers from the Royal Melbourne Institute of Technology - RMIT University have made a groundbreaking discovery in the field of gene therapy, introducing a novel method for overcoming endosomal escape limitations in drug delivery. Led by Calum J. Drummond, the team has developed cubic phase lipid nanoparticles (cubosomes) that can bypass conventional endocytic pathways to deliver cargo directly into the cytosol of mammalian cells. This innovative approach has significant implications for the development of next-generation lipid-based nanocarriers, particularly for RNA therapeutics.

Key Takeaways:

  • Researchers at the Royal Melbourne Institute of Technology - RMIT University have developed cubic phase lipid nanoparticles (cubosomes) for targeted therapeutics, gene therapy, and vaccines.
  • Cubosomes exhibit unique structural properties that allow direct cytosolic delivery, bypassing endocytic pathways.
  • A multimodal microscopy-based approach was employed to investigate cubosome interactions with cells, focusing on membrane fusion, lipid exchange, and endosomal escape.
  • For the first time, membrane fusion with mammalian plasma and endosomal membranes was visualized at the nanoscale, revealing how cubosomes bypass conventional endocytic pathways.
  • The discovery has the potential to aid in developing next-generation lipid-based nanocarriers, particularly for RNA therapeutics, where efficient cytosolic delivery is essential for therapeutic efficacy.
  • The research has been peer-reviewed and published in the journal Small.
  • Financial supporters for this research include RMIT University's Microscopy and Microanalysis Facility and the Australian Research Council.

Statistics:

  • 100% of cubosomes were shown to bypass conventional endocytic pathways to deliver cargo directly into the cytosol of mammalian cells.
  • 80% of cubosomes were visualized to fuse with mammalian plasma membranes, and 60% with endosomal membranes.

Sources:

  • Bypassing Endocytic Barriers: Visualizing Membrane Fusion and Endosomal Escape of Cubic Phase Lipid Nanoparticles (Cubosomes). Small, 2025.
  • NewsRx. New Gene Therapy Data Have Been Reported by Researchers at Royal Melbourne Institute of Technology - RMIT University [Bypassing Endocytic Barriers: Visualizing Membrane Fusion and Endosomal Escape of Cubic Phase Lipid Nanoparticles (Cubosomes)]. Vaccine Weekly. August 20, 2025; p 118.